# Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension

> **NCT00145236** · PHASE3 · COMPLETED · sponsor: **Mylan Bertek Pharmaceuticals** · enrollment: 300 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol

## Key facts

- **NCT ID:** NCT00145236
- **Lead sponsor:** Mylan Bertek Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 300 (—)
- **Last updated:** 2005-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145236, "Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00145236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*